Canopy Biosciences announces agreement with Cosmo Bio

Canopy Biosciences, LLC ("Canopy Biosciences"), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. ("Cosmo Bio") for its TUNR Flexible Gene Editing technology in Japan.  Cosmo Bio is one of Japan’s largest and most established reagents and services suppliers in the life science industry, and Canopy Biosciences will work with Cosmo Bio to gain direct access to customers and support projects throughout the Japanese academic and biopharmaceutical industry.

"We are dedicated to bringing our genetic engineering tools to researchers across the globe and expanding our footprint in Japan," said Edward Weinstein, PhD, President and CEO of Canopy Biosciences.  "Cosmo Bio is an ideal distribution partner for our genetic engineering products and services due to their deep technical expertise and fantastic customer relationships."

"The genetic engineering market continues to grow at a rapid pace in Japan and we anticipate that the TUNR technology will become a key factor in gene editing.  We are very pleased to represent Canopy Biosciences in Japan, bringing our researchers the latest genetic engineering tools," said Haruhisa Sakurai, PhD, President of Cosmo Bio.